Zepbound

Product

Heard on podcasts recently

Zepbound is a brand name for tirzepatide, an injectable prescription medication developed by Eli Lilly and Company. It is approved for chronic weight management in adults with obesity or who are overweight with weight-related medical conditions.

Rank this week

—
Not in this week’s list

Share of the conversation

—

Reach this week

—

Tone this week

—

Not enough signal yet (fewer than 3 episodes scored).

Share of the conversation

Mentions of Zepbound per 1,000 mentions of anything, 7-day rolling, all podcasts.

0.0‰0.03‰0.05‰0.07‰0.1‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Aug 290.01‰1
Sep 130.02‰2
Sep 170.04‰2
Sep 230.03‰1
Sep 300.02‰2
Oct 30.04‰2
Oct 50.04‰1
Oct 60.05‰1
Oct 200.02‰2
Oct 220.02‰1
Oct 280.02‰1
Oct 290.04‰4
Oct 300.05‰1
Oct 310.06‰1
Nov 10.08‰2
Nov 20.08‰1
Nov 50.05‰1
Nov 80.02‰1
Nov 90.04‰3
Nov 100.05‰1
Nov 170.02‰2
Nov 180.02‰1

Discussed alongside

Names that come up in the same conversations as Zepbound.

See 5 more with Pro

Embed this

Paste this on your site to show Zepbound's current trend:

<iframe src="https://podlume.ai/embed/e/work-zepbound" width="360" height="220" style="border:0" loading="lazy" title="Zepbound on PodLume Trends"></iframe>